Biotech stocks have been booming over the last few years. Anyone who has invested will have made some very respectable profits. And it's a bull market that's set to continue for some time yet.
Investors can find a wide range of profitable stocks in the biotech sector. Professional investor Dr Daniel Koller tips three to buy now.
Expanding waistlines are a global health epidemic. Smart investors should fill their boots with the firms that will profit, says Matthew Partridge.
From better drug testing to growing whole new organs – stem cell research is leading to some big investment opportunities. Matthew Partridge tips the best stocks to profit.
Bacteria are becoming increasingly resistant to antibiotics – the biotech firms developing alternatives are set to profit handsomely, says Tom Bulford.
Human body parts can now be ‘printed’ to replace defective ones. Tom Bulford looks at this exciting new technology, and focuses on one small-cap company making remarkable advances.
Pioneers of ‘wearable tech’ are predicting a glorious future for their gadgets. What are they, and will they really take off? Simon Wilson reports.
This biotech fund has already proved to be a great investment. But if you’ve missed out, Bengt Saelensminde explains why it’s not too late to get on board.
Influenza is a serious threat to world health. And there is a huge demand for a universal vaccine. Here, Matthew Partridge picks one firm that is well-placed to profit.
Despite advances, the battle against cancer was beginning to look lost. Matthew Partridge looks at the companies that have turned the tide.
Despite huge advances in medical science in recent decades, much of how the brain works remains a mystery. But this small-cap biotech company could change all that.